Telomerator-a tool for chromosome engineering

US10047366B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10047366-B2
Application numberUS-201414772832-A
CountryUS
Kind codeB2
Filing dateMar 6, 2014
Priority dateMar 6, 2013
Publication dateAug 14, 2018
Grant dateAug 14, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the field of chromosome engineering. More specifically, the present invention provides methods and compositions useful for inducibly linearizing circular DNA molecules in vivo in yeast. In one embodiment, a comprises a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding a selectable marker comprises an intron comprising an endonuclease recognition site flanked by telomere seed sequences.

First claim

Opening claim text (preview).

We claim: 1. A telomerator cassette comprising a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding a selectable marker is interrupted by an intron comprising an endonuclease recognition site flanked by telomere seed sequences. 2. The telomerator cassette of claim 1 , wherein the intron is the ACT1 intron. 3. The telomerator cassette of claim 1 , wherein the selectable marker is an auxotrophic marker. 4. The telomerator cassette of claim 3 , wherein the auxotrophic marker is the URA3 gene. 5. The telomerator cassette of claim 1 , wherein the endonuclease recognition site is specific for I-SceI. 6. The telomerator cassette of claim 5 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 7. The telomerator cassette of claim 1 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 8. A circular chromosome comprising the telomerator cassette of claim 1 . 9. A eukaryotic host cell comprising the circular chromosome of claim 8 . 10. The eukaryotic host cell of claim 9 , wherein the eukaryote is yeast. 11. The eukaryotic host cell of claim 10 , wherein the yeast is S. cerevisiae. 12. The eukaryotic host cell of claim 9 , wherein the host cell comprises a vector encoding the endonuclease under the control of an inducible promoter. 13. A telomerator cassette comprising a nucleic acid that encodes the auxotrophic marker URA3, wherein the nucleic acid is interrupted by an intron that comprises the I-SceI endonuclease recognition site flanked by telomere seed sequences. 14. The telomerator cassette of claim 13 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 15. The telomerator cassette of claim 13 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 16. A circular chromosome comprising the telomerator cassette of claim 13 . 17. A yeast host cell comprising the circular chromosome of claim 16 . 18. The yeast host cell of claim 17 , wherein the yeast host cell comprises a vector encoding the I-SceI endonuclease under the control of an inducible promoter. 19. The yeast host cell of claim 18 , wherein the inducible promoter is the GAL1 promoter. 20. A yeast host cell comprising: a. a circular chromosome comprising a telomerator cassette encoding a selectable marker, wherein the nucleic acid encoding the selectable marker is interrupted by an intron that comprises an endonuclease recognition site flanked by telomere seed sequences; and b. a vector encoding the endonuclease under the control of an inducible promoter. 21. The yeast host cell of claim 20 , wherein the selectable marker is an auxotrophic marker. 22. The yeast host cell of claim 21 , wherein the auxotrophic marker is the URA3 gene. 23. The yeast host cell of claim 20 , wherein the endonuclease recognition site is specific for I-SceI. 24. The yeast host cell of claim 23 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 25. The yeast host cell of claim 20 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 26. A method for engineering a circular chromosome capable of being inducibly linearized comprising the step of integrating a telomerator cassette into a circular chromosome, wherein the telomerator cassette comprises a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding a selectable marker is interrupted by an intron comprising an endonuclease recognition site flanked by telomere seed sequences. 27. The method of claim 26 , wherein the integrating step is accomplished by transforming a telomerator cassette into a host cell comprising the circular chromosome. 28. The method of claim 27 , wherein the host cell comprises a vector encoding the endonuclease under the control of an inducible promoter. 29. A telomerator cassette comprising a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding the selectable marker is interrupted by an endonuclease recognition site flanked by telomere seed sequences such that the selectable marker retains its function. 30. The telomerator cassette of claim 29 , wherein the selectable marker is an auxotrophic marker. 31. The telomerator cassette of claim 30 , wherein the auxotrophic marker is the URA3 gene. 32. The telomerator cassette of claim 29 , wherein the endonuclease recognition site is specific for I-SceI. 33. The telomerator cassette of claim 32 , wherein the I-SceI endonuclease recognition site comprises SEQ ID NO:2. 34. The telomerator cassette of claim 29 , wherein the telomere seed sequences comprise SEQ ID NO:1 and SEQ ID NO:3. 35. A circular chromosome comprising the telomerator cassette of claim 29 . 36. A eukaryotic host cell comprising the circular chromosome of claim 35 .

Assignees

Inventors

Classifications

  • Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites · CPC title

  • using markers (enzymes used as markers C12N15/52) · CPC title

  • C12N15/81Primary

    for yeasts · CPC title

  • in yeast · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10047366B2 cover?
The present invention relates to the field of chromosome engineering. More specifically, the present invention provides methods and compositions useful for inducibly linearizing circular DNA molecules in vivo in yeast. In one embodiment, a comprises a nucleic acid encoding a selectable marker, wherein the nucleic acid encoding a selectable marker comprises an intron comprising an endonuclease r…
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification C12N15/81. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).